Explore how functional precision medicine is revolutionizing glioblastoma treatment through patient-derived organoids and drug sensitivity testing.
Scientists discover how SOCS1 and SOCS3 proteins work together to make glioblastoma tumors resistant to radiation therapy.
Exploring the unexpected connection between anti-epileptic drugs and glioblastoma treatment through multi-omic insights and xenograft studies.
Revolutionary nanomedicine approach using reciprocal dormancy-promoting therapy to manage glioblastoma by targeting EGFR and TSP-1 pathways.